Xiaowei Liu
- Molecular Biology top 5%
- Biomedical Engineering top 10%
- Oncology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Topics
- RNA Interference and Gene Delivery (8 papers)Cancer Immunotherapy and Biomarkers (8 papers)Advanced biosensing and bioanalysis techniques (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaowei Liu
60 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Biology 1.6k
- Biomedical Engineering 391
- Oncology 388
- Immunology 274
- Cancer Research 251
Countries citing papers authored by Xiaowei Liu
This map shows the geographic impact of Xiaowei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Liu more than expected).
Fields of papers citing papers by Xiaowei Liu
This network shows the impact of papers produced by Xiaowei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Liu. The network helps show where Xiaowei Liu may publish in the future.
Co-authorship network of co-authors of Xiaowei Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Liu. A scholar is included among the top collaborators of Xiaowei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Liu. Xiaowei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 4 | |
| 6 | 11 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillancebreakdown → | 217 |
| 10 | 15 | |
| 11 | 4 | |
| 12 | 26 | |
| 13 | 16 | |
| 14 | 35 | |
| 15 | 20 | |
| 16 | 6 | |
| 17 | 15 | |
| 18 | 30 | |
| 19 | 7 | |
| 20 | 39 |
About Xiaowei Liu
Xiaowei Liu is a scholar working on Cancer Research, Health Informatics and Molecular Biology, having authored 63 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). The work is most often cited by research in Molecular Biology (1.6k citations), Cancer Research (251 citations) and Health Informatics (21 citations). Xiaowei Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hubing Shi, Hao Yan, Jing Jing, Xing‐Jie Liang, Dengli Qiu, Lin Lin, Jeanette Nangreave, Baoquan Ding, Guozhang Zou and Qiao Jiang. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.